Beng K Yap

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Emma Hall, Kevin J Harrington, S. Bhide, 2011, The Lancet. Oncology.

IMRT dose fractionation for head and neck cancer: Variation in current approaches will make standardisation difficult

J. Fowler, N. Slevin, L. Lee, 2009, Acta oncologica.